Humanized anti-interleukin 6 receptor antibody induced long-term remission in a patient with life-threatening refractory autoimmune hemolytic anemia

International Journal of Hematology

Volumn 80, Issue 3, 2004, Pages 246-249

  Kunitomi, Akane ^a,c   Konaka, Yoshiteru ^a   Yagita, Masato ^a   Nishimoto, Norihiro ^b   Kishimoto, Tadamitsu ^b   Takatsuki, Kiyoshi ^a  

^a Kitano Hospital   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

AIHA; Humanized anti IL 6 receptor antibody; IL 6

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 6 RECEPTOR; MELPHALAN; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; HUMAN; IRRADIATION; MALE; PLASMAPHERESIS; REFRACTORY ANEMIA; REMISSION; SIDE EFFECT;

ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; CRITICAL ILLNESS; DRUG EVALUATION; HUMANS; INTERLEUKIN-6; MALE; RECEPTORS, INTERLEUKIN-6; REMISSION INDUCTION; SALVAGE THERAPY; TIME;

EID: 6944219975     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04058     Document Type: Article

References (18)

1. Claire H. Autoimmune hemolytic anemia. Clin Rev Allergy Immunol. 1998;16:285-295.
2. Bradley CG, Richard CF. Autoimmune hemolytic anemia. Am J Hematol. 2002;69:258-271.
3. Gupta N, Kavuru S, Patel D, et al. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia. Leukemia. 2002;16:2092-2095.
4. Perrotta S, Locatelli F, La Manna A, Cennamo L, De Stefano P, Nobili B. Anti-CD20 monoclonal antibody (rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus. Br J Haematol. 2002;116:465-467.
5. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today. 1990;11:443-449.
6. Hirano T. Interleukin 6 and autoimmunity and plasma cell neoplasias. Res Immunol. 1992;143:759-763.
7. Choy EH, Isenberg DA, Garrood T, et al. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum. 2002;46:3143-3150.
8. Atreya R, Mudter J, Finotto S, et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med. 2000;6:583-588.
9. Iwamoto M, Nara H, Hirata D, Minota S, Nishimoto N, Yoshizaki K. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease. Arthritis Rheum. 2002;46:3388-3389.
10. Barcellini W, Clerici G, Montesano R, et al. In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation. Br J Haematol. 2000;111:452-460.
11. Barcellini W, Montesano R, Clerici G, et al. In vitro production of anti-RBC antibodies and cytokines in chronic lymphocytic leukemia. Am J Hematol. 2002;71:177-183.
12. Lapierre Y, et al. The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion. 1990;30:109-113.
13. Nishimoto N, Sasai M, Shima Y, et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood. 2000;95:56-61.
14. Schuerwegh AJ, Van Offel JF, Stevens WJ, Bridts CH, De Clerck LS. Influence of therapy with chimeric monoclonal tumour necrosis factor-α antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients. Rheumatology (Oxford). 2003;42:541-548.
15. Sun Y, Chen HM, Subudhi SK, et al. Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nat Med. 2002;8:1405-1413.
16. Monteleone G, MacDonald TT. Manipulation of cytokines in the management of patients with inflammatory bowel disease. Ann Med. 2000;32:552-560.
17. Stasi R, Pagano A, Stipa E, Amadori S. Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura. Blood. 2002;99:3872-3873.
18. Weide R, Heymanns J, Pandorf A, Koppler H. Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy. Lupus. 2003;12:779-782.